InvestorsHub Logo
Followers 32
Posts 4249
Boards Moderated 0
Alias Born 07/25/2007

Re: Inoviorulez post# 771

Tuesday, 01/14/2020 2:33:31 PM

Tuesday, January 14, 2020 2:33:31 PM

Post# of 977

Let people be ignorant. Trillium's products TTI-621 and TTI-622 are superior to FTSV's magrolimab. TRIL should be equal in market cap to FTSV right now. Obviously it won't gap that high immediately, but over time it will start to trend and trade up higher until it matches it valuation. The smart people are accumulating now, those types are bashing it.



Thanks for that nice summary. Letting people remain ignorant is different from letting people be lied to or misinformed. I will point out that FTSV has a nice chunk of cash on hand but TRIL doesn't. That lack of cash and the threat of delisting has hurt TRIL. For the latter, if TRIL closes over $1 today it will be the 10th straight day so the threat of delisting will be gone. That will be a relief and a positive for shareholders.